Available Molecular Tests for Solid Tumors
Andrew McKenzie, PhD, provides an overview of the various forms of molecular testing available for identifying actionable alterations in breast and lung cancer.
Now Viewing
EP: 1.Available Molecular Tests for Solid Tumors
EP: 2.Using Molecular Testing to Guide Treatment Decisions
EP: 3.PD-L1 Expression and IO Therapy in Lung and Breast Cancer
EP: 4.Clinical Scenario: A 44-Year-Woman with Metastatic Breast Cancer
EP: 5.Currently Targetable Mutations in Lung and Breast Cancer
EP: 6.Choosing a Molecular Testing Panel for Solid Tumors
EP: 7.Biomarker Testing Interpretation in Breast and Lung Cancer
EP: 8.Challenges of Biomarker Testing in Breast Cancer
EP: 9.Use of Liquid Biopsies in Breast Cancer
EP: 10.Discussing Biomarker Testing with Patients
EP: 11.Biomarker-Influenced Treatment Approaches for Patients with Metastatic Lung Cancer
EP: 12.Clinical Scenario: A 74-Year-Old Man with Lung Cancer
EP: 13.Further Molecular Testing in Early-Stage Metastatic Breast Cancer
EP: 14.Targeted Therapy in Metastatic Breast Cancer for Patients with BRCA Mutations
EP: 15.Monitoring Patients on First-Line Treatment for Metastatic Breast Cancer
EP: 16.Biomarker Testing Standards-of-Care in Breast and Lung Cancer
Related Videos
Related Content
